245 related articles for article (PubMed ID: 17654117)
1. INK4 proteins, a family of mammalian CDK inhibitors with novel biological functions.
Cánepa ET; Scassa ME; Ceruti JM; Marazita MC; Carcagno AL; Sirkin PF; Ogara MF
IUBMB Life; 2007 Jul; 59(7):419-26. PubMed ID: 17654117
[TBL] [Abstract][Full Text] [Related]
2. Genetic cooperation between p21Cip1 and INK4 inhibitors in cellular senescence and tumor suppression.
Quereda V; Martinalbo J; Dubus P; Carnero A; Malumbres M
Oncogene; 2007 Dec; 26(55):7665-74. PubMed ID: 17599058
[TBL] [Abstract][Full Text] [Related]
3. Tumor suppressor INK4: comparisons of conformational properties between p16(INK4A) and p18(INK4C).
Yuan C; Li J; Selby TL; Byeon IJ; Tsai MD
J Mol Biol; 1999 Nov; 294(1):201-11. PubMed ID: 10556039
[TBL] [Abstract][Full Text] [Related]
4. RhoA regulates G1-S progression of gastric cancer cells by modulation of multiple INK4 family tumor suppressors.
Zhang S; Tang Q; Xu F; Xue Y; Zhen Z; Deng Y; Liu M; Chen J; Liu S; Qiu M; Liao Z; Li Z; Luo D; Shi F; Zheng Y; Bi F
Mol Cancer Res; 2009 Apr; 7(4):570-80. PubMed ID: 19372585
[TBL] [Abstract][Full Text] [Related]
5. Limited overlapping roles of P15(INK4b) and P18(INK4c) cell cycle inhibitors in proliferation and tumorigenesis.
Latres E; Malumbres M; Sotillo R; Martín J; Ortega S; Martín-Caballero J; Flores JM; Cordón-Cardo C; Barbacid M
EMBO J; 2000 Jul; 19(13):3496-506. PubMed ID: 10880462
[TBL] [Abstract][Full Text] [Related]
6. Backbone dynamics of the CDK inhibitor p19(INK4d) studied by 15N NMR relaxation experiments at two field strengths.
Renner C; Baumgartner R; Noegel AA; Holak TA
J Mol Biol; 1998; 283(1):221-9. PubMed ID: 9761685
[TBL] [Abstract][Full Text] [Related]
7. Distinct versus redundant properties among members of the INK4 family of cyclin-dependent kinase inhibitors.
Thullberg M; Bartkova J; Khan S; Hansen K; Rönnstrand L; Lukas J; Strauss M; Bartek J
FEBS Lett; 2000 Mar; 470(2):161-6. PubMed ID: 10734227
[TBL] [Abstract][Full Text] [Related]
8. Cell survival, cell death and cell cycle pathways are interconnected: implications for cancer therapy.
Maddika S; Ande SR; Panigrahi S; Paranjothy T; Weglarczyk K; Zuse A; Eshraghi M; Manda KD; Wiechec E; Los M
Drug Resist Updat; 2007; 10(1-2):13-29. PubMed ID: 17303468
[TBL] [Abstract][Full Text] [Related]
9. The regulation of INK4/ARF in cancer and aging.
Kim WY; Sharpless NE
Cell; 2006 Oct; 127(2):265-75. PubMed ID: 17055429
[TBL] [Abstract][Full Text] [Related]
10. Structure of human cyclin-dependent kinase inhibitor p19INK4d: comparison to known ankyrin-repeat-containing structures and implications for the dysfunction of tumor suppressor p16INK4a.
Baumgartner R; Fernandez-Catalan C; Winoto A; Huber R; Engh RA; Holak TA
Structure; 1998 Oct; 6(10):1279-90. PubMed ID: 9782052
[TBL] [Abstract][Full Text] [Related]
11. Mouse p10, an alternative spliced form of p15INK4b, inhibits cell cycle progression and malignant transformation.
Pérez de Castro I; Benet M; Jiménez M; Alzabin S; Malumbres M; Pellicer A
Cancer Res; 2005 Apr; 65(8):3249-56. PubMed ID: 15833857
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic inactivation of INK4/CDK/RB cell cycle pathway in acute leukemias.
Chim CS; Wong AS; Kwong YL
Ann Hematol; 2003 Dec; 82(12):738-42. PubMed ID: 14513284
[TBL] [Abstract][Full Text] [Related]
13. The COOH terminus of p18INK4C distinguishes function from p16INK4A.
Gump J; Turner S; Koh J
Cancer Res; 2001 May; 61(10):3863-8. PubMed ID: 11358797
[TBL] [Abstract][Full Text] [Related]
14. Expression of p16Ink4a compensates for p18Ink4c loss in cyclin-dependent kinase 4/6-dependent tumors and tissues.
Ramsey MR; Krishnamurthy J; Pei XH; Torrice C; Lin W; Carrasco DR; Ligon KL; Xiong Y; Sharpless NE
Cancer Res; 2007 May; 67(10):4732-41. PubMed ID: 17510401
[TBL] [Abstract][Full Text] [Related]
15. Ara-c induces cell cycle G1/S arrest by inducing upregulation of the INK4 family gene or directly inhibiting the formation of the cell cycle-dependent complex CDK4/cyclin D1.
Sun F; Li N; Tong X; Zeng J; He S; Gai T; Bai Y; Liu L; Lu K; Shen J; Han M; Lu C; Dai F
Cell Cycle; 2019 Sep; 18(18):2293-2306. PubMed ID: 31322047
[TBL] [Abstract][Full Text] [Related]
16. Posttranscriptional induction of p21Waf1 mediated by ectopic p16INK4 in human diploid fibroblast.
Han XL; Wu FG; Zhang ZY; Tong TJ
Chin Med J (Engl); 2007 Mar; 120(5):405-9. PubMed ID: 17376312
[TBL] [Abstract][Full Text] [Related]
17. Cell-cycle molecules in mesothelioma: an overview.
Spugnini EP; Campioni M; D'Avino A; Caruso G; Citro G; Baldi A
J Exp Clin Cancer Res; 2007 Dec; 26(4):443-9. PubMed ID: 18365537
[TBL] [Abstract][Full Text] [Related]
18. Identification of calpain cleavage sites in the G1 cyclin-dependent kinase inhibitor p19(INK4d).
Joy J; Nalabothula N; Ghosh M; Popp O; Jochum M; Machleidt W; Gil-Parrado S; Holak TA
Biol Chem; 2006 Mar; 387(3):329-35. PubMed ID: 16542156
[TBL] [Abstract][Full Text] [Related]
19. The INK4-ARF (CDKN2A/B) locus in hematopoiesis and BCR-ABL-induced leukemias.
Williams RT; Sherr CJ
Cold Spring Harb Symp Quant Biol; 2008; 73():461-7. PubMed ID: 19028987
[TBL] [Abstract][Full Text] [Related]
20. Differential post-transcriptional regulation of two Ink4 proteins, p18 Ink4c and p19 Ink4d.
Forget A; Ayrault O; den Besten W; Kuo ML; Sherr CJ; Roussel MF
Cell Cycle; 2008 Dec; 7(23):3737-46. PubMed ID: 19029828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
